I appreciate the effort you have gone to address this specifically for me. I concede that the conclusion can only but be as you and the company present it. The sticking point, for me, is the fact that the original Ph 1B trial at the COH has not been updated (aka categorised as "Suspended" or "Terminated") in line with the proposed new one. Is that typical on the Clinical Trials site?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)